Metraipolis › archive › dc_990ba00aad52

The impact of SGLT2 inhibitors on uric acid levels in patients with heart failure with preserved ejection fraction: integration of mechanisms and clinical… — Europe PMC PMID:42630837

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42630837
DOI: 10.3389/fcvm.2026.1726611
License (as archived): solo-consultazione
Archived: 2026-10-07T13:34:30.299Z
SHA-256 of the archived text: 5709940afd6eae5b97554b21ffeecec802a2984d602f9df228e2aacac3be0600
Stable URL of this page: https://metraipolis.com/documento/dc_990ba00aad52

How to cite

The impact of SGLT2 inhibitors on uric acid levels in patients with heart failure with preserved ejection fraction: integration of mechanisms and clinical… — Europe PMC PMID:42630837 — Europe PMC (en), https://europepmc.org/article/MED/42630837 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_990ba00aad52 (Metraipolis archive dc_990ba00aad52, sha256 5709940afd6eae5b97554b21ffeecec802a2984d602f9df228e2aacac3be0600)

BibTeX

@misc{dc990ba00aad52,
  title = {The impact of SGLT2 inhibitors on uric acid levels in patients with heart failure with preserved ejection fraction: integration of mechanisms and clinical… — Europe PMC PMID:42630837},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42630837},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_990ba00aad52; sha256 5709940afd6eae5b97554b21ffeecec802a2984d602f9df228e2aacac3be0600},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42630837. Agents can read the archived copy with the MCP tool read_document.